Rafferty Asset Management
FLNA

Rafferty Asset Management’s Filana Therapeutics FLNA Stock Holding History

Rafferty Asset Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-12,487
Closed -$367K – 1172
2024
Q3 		$367K Buy
12,487
+1,230
+11% +$28.3K ﹤0.01% 1003
2024
Q2 		$139K Buy
11,257
+1,287
+13% +$27.1K ﹤0.01% 1153
2024
Q1 		$202K Buy
+9,970
New +$230K ﹤0.01% 1063
2023
Q2 		– Sell
-9,167
Closed -$221K – 1138
2023
Q1 		$221K Buy
9,167
+1,519
+20% +$42.1K ﹤0.01% 1095
2022
Q4 		$226K Buy
7,648
+163
+2% +$5.86K ﹤0.01% 1062
2022
Q3 		$313K Sell
7,485
-1,138
-13% -$30.7K ﹤0.01% 982
2022
Q2 		$242K Sell
8,623
-3,538
-29% -$89.3K ﹤0.01% 1001
2022
Q1 		$452K Sell
12,161
-7,481
-38% -$317K ﹤0.01% 1032
2021
Q4 		$858K Buy
19,642
+4,508
+30% +$236K ﹤0.01% 936
2021
Q3 		$940K Buy
15,134
+8,596
+131% +$717K 0.01% 853
2021
Q2 		$559K Buy
+6,538
New +$350K ﹤0.01% 1051

Other funds holding FLNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Rafferty Asset Management's FLNA Position: Q4 2024 in Review

Rafferty Asset Management sold out of Filana Therapeutics (FLNA) in Q4 2024, closing a stake of 12,487 shares — an estimated $367K sold.

Rafferty Asset Management first reported a position in FLNA in Q2 2021 and held it in 11 quarters. The position peaked at $940K in Q3 2021. 137 funds tracked by Wall St. Rank hold FLNA as of Q4 2024.

  • Rafferty Asset Management reported no remaining Filana Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Rafferty Asset Management sold 12,487 Filana Therapeutics shares in Q4 2024, an estimated $367K.
  • Rafferty Asset Management first reported a position in Filana Therapeutics in Q2 2021 and held it in 11 quarters.
  • Rafferty Asset Management's Filana Therapeutics position peaked at $940K in Q3 2021.
  • 137 funds tracked by Wall St. Rank held Filana Therapeutics as of Q4 2024.

Based on Rafferty Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.